What the VRAYLAR TV commercial - Elevator is about.
The VRAYLAR TV Spot, 'Elevator' is a powerful and thought-provoking commercial that depicts the struggles of individuals with bipolar disorder. The commercial takes place entirely within the confines of an elevator, and it features a man and a woman who are both dealing with the disorder.
As the elevator begins to ascend, the woman starts to feel anxious and overwhelmed, while the man looks on, seemingly unfazed. However, as the elevator continues to rise, the man suddenly begins to experience the same symptoms of anxiety and distress as the woman.
The commercial seamlessly weaves together the emotional and physical effects of bipolar disorder, highlighting the different ways that it can manifest in different individuals. The message is clear – bipolar disorder is a serious condition that affects millions of people around the world, and it is important to seek help and treatment.
The commercial ends with a message of hope, as the man and woman are shown outside of the elevator, having received the treatment they need to manage their symptoms. The tagline, "Talk to your doctor about treating bipolar depression" reinforces the importance of seeking professional help and underscores the message that there are effective treatments available for those struggling with bipolar disorder. Overall, the VRAYLAR TV Spot, 'Elevator' is a poignant and impactful commercial that highlights an important issue while also providing hope and encouragement to those who may be struggling with bipolar disorder.
VRAYLAR TV commercial - Elevator produced for
VRAYLAR
was first shown on television on September 9, 2019.
Frequently Asked Questions about vraylar tv spot, 'elevator'
VRAYLAR is a prescription medicine used in adults: along with antidepressant medicines to treat major depressive disorder (MDD) for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder. to treat depressive episodes that happen with bipolar I (dipolar depression)
VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*
Not approved for use by anyone younger than 18 years old. Hypersensitivity reactions have been reported. Vraylar should not be taken by people who are allergic to any ingredients in the product. Vraylar may potentially harm an unborn baby.
Within the first 1-2 weeks hallucinations, disorganized thinking and delusions may improve. After 1-2 weeks patients may feel more motivated and have a greater desire to be around other people.
Vraylar helps balance the levels of neurotransmitters in your brain. Neurotransmitters are chemicals that help your brain cells communicate with each other. The main neurotransmitters affected by Vraylar are dopamine and serotonin. Dopamine plays a role in causing hallucinations, delusions, and thought disorders.
Effectiveness for manic or mixed episodes
Vraylar was found to be effective for treating manic or mixed episodes of bipolar I disorder in three clinical trials that lasted 3 weeks.
Cariprazine is a medication that works in the brain to treat schizophrenia and bipolar disorder. It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic. Cariprazine rebalances dopamine and serotonin to improve thinking, mood, and behavior.
In 6-week and 8-week bipolar I depression studies, about 7% of patients who took VRAYLAR felt sleepy or drowsy, compared to 4% of patients taking placebo. At a higher dose in 3-week bipolar I mania clinical studies, 8% of patients with bipolar I disorder who took VRAYLAR felt sleepy or drowsy.
Cariprazine is a medication that works in the brain to treat schizophrenia and bipolar disorder. It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic. Cariprazine rebalances dopamine and serotonin to improve thinking, mood, and behavior.
Up to 10% of people taking Vraylar report sleepiness or drowsiness as a side effect; the risk of this side effect increases with higher dosages, and these people may prefer taking it at night.
VRAYLAR works to help control the mood swings of bipolar I disorder in adults, providing full-spectrum relief for all bipolar I symptoms: bipolar I depression and acute manic or mixed episodes. Studies have shown VRAYLAR can: Improve overall depressive and manic symptoms*
Within the first 1-2 weeks hallucinations, disorganized thinking and delusions may improve. After 1-2 weeks patients may feel more motivated and have a greater desire to be around other people.
![Lexus Golden Opportunity Sales Event TV Spot, 'Always in Your Element' [T1]](https://connect4productions.com/image/Lexus%20Golden%20Opportunity%20Sales%20Event%20TV%20Spot,%20%27Always%20in%20Your%20Element%27%20%5BT1%5D/tv "Lexus Golden Opportunity Sales Event TV Spot, 'Always in Your Element' [T1]")
